FOP News

The International Clinical Council on FOP

Optimizing care for the FOP patient

Read more Share

BioCryst Pharmaceuticals Announcement of Potential Drug Treatment

Exploring treatment for FOP

Read more Share

FOP Clinical Trial Update

Original posting updated on Nov. 30, 2017

Two pharmaceutical companies are now recruiting for FOP clinical trials

Read more Share

FDA Grants Breakthrough Therapy Designation to Clementia's Palovarotene

New developments after evaluation of preliminary study data

Read more Share

Annual Report of the FOP Collaborative Research Project

The 26th Annual Report Is Here!

Read more Share

Regeneron Receives Fast Track Designation from U.S. FDA for REGN 2477

Speeding up the process

Read more Share

New FOP Clinical Trial to Begin in Japan

The IFOPA is encouraged to see a clinical trial for FOP beginning in Japan.

Read more Share

FOP Research at the University of Michigan

IFOPA Board Member, Gary McGuire, and his daughter, Natalie, recently visited Dr. Ben Levi at his lab to discuss the FOP research being performed at the University of Michigan.

Read more Share

Clementia Announces Symposium at the 8th International Conference on Children's Bone Health (ICCBH)

An important announcement from Clementia

Read more Share

Clementia Announces Preliminary Results of its Phase 2 Trial in Treatment of FOP

An important announcement from Clementia

The IFOPA is pleased to share this announcement from Clementia Pharmaceuticals: Top-line Results from Phase 2 Trial of Palovarotene for Treatment of Patients with FOP. Read more.


Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter